Meta-analyses of Results From Randomized Outcome Trials Comparing Cardiovascular Effects of SGLT2is and GLP-1RAs in Asian Versus White Patients With and Without Type 2 Diabetes

Analysis suggests that compared with Whites, Asians with heart failure (HF) with reduced ejection fraction may have larger reduction in risk of CV death/HF hospitalisation with SGLT2is, and those with type 2 diabetes a larger reduction in MACE risk with GLP-1RAs.

Source:

Diabetes Care